ZA913071B - Treatment - Google Patents

Treatment

Info

Publication number
ZA913071B
ZA913071B ZA913071A ZA913071A ZA913071B ZA 913071 B ZA913071 B ZA 913071B ZA 913071 A ZA913071 A ZA 913071A ZA 913071 A ZA913071 A ZA 913071A ZA 913071 B ZA913071 B ZA 913071B
Authority
ZA
South Africa
Prior art keywords
treatment
arrythmias
atrial
cardiac
stroke
Prior art date
Application number
ZA913071A
Other languages
English (en)
Inventor
Alberto Julio Kaumann
Julio Kaumann Alberto
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA913071B publication Critical patent/ZA913071B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polarising Elements (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ZA913071A 1990-04-26 1991-04-24 Treatment ZA913071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009389A GB9009389D0 (en) 1990-04-26 1990-04-26 Treatment

Publications (1)

Publication Number Publication Date
ZA913071B true ZA913071B (en) 1992-11-25

Family

ID=10675031

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913071A ZA913071B (en) 1990-04-26 1991-04-24 Treatment

Country Status (14)

Country Link
EP (1) EP0526540B1 (de)
JP (2) JPH05509293A (de)
AT (1) ATE181668T1 (de)
AU (1) AU653521B2 (de)
CA (1) CA2081344C (de)
DE (1) DE69131398T2 (de)
DK (1) DK0526540T3 (de)
ES (1) ES2134774T3 (de)
GB (1) GB9009389D0 (de)
GR (1) GR3031042T3 (de)
IE (1) IE911383A1 (de)
PT (1) PT97477B (de)
WO (1) WO1991016045A2 (de)
ZA (1) ZA913071B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
JPH08502283A (ja) * 1992-10-16 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用の縮合環系ｎ−アルキルピペリジニル−４−メチルカルボン酸エステル／アミド
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
CA2160420A1 (en) * 1994-10-20 1996-04-21 Haruhiko Kikuchi 5-ht4 receptor agonists
JP2004505930A (ja) * 2000-08-07 2004-02-26 ラボラトワール・グラクソスミスクライン・ソシエテ・パール・アクシオン・シンプリフィエ 心房細動の予防または治療のための薬物の製造における５ｈｔ４受容体アンタゴニストの使用
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP1758891A2 (de) 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazoloncarbonsäurederivate
EP2153830A1 (de) * 2008-08-07 2010-02-17 Sanofi-Aventis Verwendung von Dronedaron zur Herstellung eines Medikaments zur Prävention von Schlaganfällen oder transienten ischämischen Anfällen
CA2956699C (en) 2014-07-30 2020-09-29 Aetas Pharma Co., Ltd. Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0200444B1 (de) * 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazol-carboxamid mit 5-HT-antagonistischer Wirkung
US4731643A (en) * 1985-10-21 1988-03-15 International Business Machines Corporation Logic-circuit layout for large-scale integrated circuits

Also Published As

Publication number Publication date
PT97477B (pt) 1998-08-31
DE69131398D1 (de) 1999-08-05
EP0526540B1 (de) 1999-06-30
JPH05509293A (ja) 1993-12-22
WO1991016045A3 (en) 1991-12-26
IE911383A1 (en) 1991-11-06
CA2081344A1 (en) 1991-10-27
JP2003267890A (ja) 2003-09-25
ES2134774T3 (es) 1999-10-16
DE69131398T2 (de) 2000-03-02
WO1991016045A2 (en) 1991-10-31
AU653521B2 (en) 1994-10-06
ATE181668T1 (de) 1999-07-15
CA2081344C (en) 2003-10-21
AU7768091A (en) 1991-11-11
DK0526540T3 (da) 1999-11-22
GB9009389D0 (en) 1990-06-20
EP0526540A1 (de) 1993-02-10
GR3031042T3 (en) 1999-12-31
PT97477A (pt) 1992-01-31

Similar Documents

Publication Publication Date Title
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
GB9009389D0 (en) Treatment
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
EP0547178A4 (en) Novel cholecystokinin antagonists, their preparation and therapeutic use
AU4163793A (en) Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
AU9084191A (en) Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
EP0437026A3 (en) Use of tandospirone in the treatment of depression
AU9071291A (en) Use of angiotensin ii antagonists in the treatment of left ventricular hypertrophy
AU9064191A (en) Use of angiotensin ii receptor antagonists in the treatment of atheroma
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
EP0276573A3 (en) Use of 24,25-dihydroxycholecalciferol in the prophylaxis of bone senescence
EP0427458A3 (en) Use of heptapeptides in the treatment or prophylaxis of muscle wasting
GR890100642A (en) Ultra mild skin cleansing composition
KR0139221B1 (en) Use of chlormethiazole in the prevention and/or treatment of neurodegeneration
GB9011406D0 (en) Hair-bearing skin area treatment
EP0565674A4 (de)
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
ES1021961Y (es) Aparato para el lavado y masajeado de la espalda y zonas lumbares del cuerpo humano.
GB2245475B (en) Improvements in the treatment of animal feeds
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.
EP0596359A3 (de) Fluorierte 1,3-Benzo- und 1,3-Pyrido-dioxole, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Pflanzenschutzmitteln.
BR6900443U (pt) Disposicao introduzida em valvula cardiaca
EP0452941A3 (en) Use of isomonools in the treatment and prophylaxis of cancer